CS151744B1 - - Google Patents
Info
- Publication number
- CS151744B1 CS151744B1 CS357A CS35771A CS151744B1 CS 151744 B1 CS151744 B1 CS 151744B1 CS 357 A CS357 A CS 357A CS 35771 A CS35771 A CS 35771A CS 151744 B1 CS151744 B1 CS 151744B1
- Authority
- CS
- Czechoslovakia
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS357A CS151744B1 (https=) | 1971-01-19 | 1971-01-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS357A CS151744B1 (https=) | 1971-01-19 | 1971-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS151744B1 true CS151744B1 (https=) | 1973-11-19 |
Family
ID=5335504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS357A CS151744B1 (https=) | 1971-01-19 | 1971-01-19 |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS151744B1 (https=) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002074750A1 (en) * | 2001-03-15 | 2002-09-26 | Astrazeneca Ab | Metalloproteinase inhibitors |
| WO2002074748A1 (en) | 2001-03-15 | 2002-09-26 | Astrazeneca Ab | Metalloproteinase inhibitors |
| US7482372B2 (en) | 2001-05-25 | 2009-01-27 | Bristol-Myers Squibb Company | Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
-
1971
- 1971-01-19 CS CS357A patent/CS151744B1/cs unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002074750A1 (en) * | 2001-03-15 | 2002-09-26 | Astrazeneca Ab | Metalloproteinase inhibitors |
| WO2002074748A1 (en) | 2001-03-15 | 2002-09-26 | Astrazeneca Ab | Metalloproteinase inhibitors |
| EP1676846A2 (en) | 2001-03-15 | 2006-07-05 | AstraZeneca AB | Hydantoin derivatives as MMP inhibitors |
| RU2285695C2 (ru) * | 2001-03-15 | 2006-10-20 | Астразенека Аб | Производные имидазолидин-2,4-диона, содержащие их фармацевтические композиции и их применение |
| US7482372B2 (en) | 2001-05-25 | 2009-01-27 | Bristol-Myers Squibb Company | Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |